ABROGATION OF CHEMOTHERAPY-INDUCED LYMPHOCYTE DECLINE BY SUBCUTANEOUS LOW-DOSE IL-2 ADMINISTRATION IN ADVANCED NON-SMALL CELL LUNG CANCER


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles